10x Genomics, Inc. reported earnings results for the second quarter and six months ended June 30, 2025. For the second quarter, the company reported revenue was USD 172.91 million compared to USD 153.1 million a year ago. Revenue was USD 172.91 million compared to USD 153.1 million a year ago. Revenue was USD 172.91 million compared to USD 153.1 million a year ago. Revenue was USD 172.91 million compared to USD 153.1 million a year ago. Net income was USD 34.54 million compared to net loss of USD 37.9 million a year ago. Net income was USD 34.54 million compared to net loss of USD 37.9 million a year ago. Net income was USD 34.54 million compared to net loss of USD 37.9 million a year ago. Net income was USD 34.54 million compared to net loss of USD 37.9 million a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.32 a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.32 a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.32 a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.32 a year ago.
For the six months, revenue was USD 327.79 million compared to USD 294.11 million a year ago. Revenue was USD 327.79 million compared to USD 294.11 million a year ago. Revenue was USD 327.79 million compared to USD 294.11 million a year ago. Revenue was USD 327.79 million compared to USD 294.11 million a year ago. Net income was USD 0.18 million compared to net loss of USD 97.85 million a year ago. Net income was USD 0.18 million compared to net loss of USD 97.85 million a year ago. Net income was USD 0.18 million compared to net loss of USD 97.85 million a year ago. Net income was USD 0.18 million compared to net loss of USD 97.85 million a year ago.